The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,398.00
Bid: 12,396.00
Ask: 12,400.00
Change: 66.00 (0.54%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,408.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar hits two-year lows as traders ignore U.S. stimulus delays

Wed, 30th Dec 2020 08:57

* Dollar falls to lowest since April 2018

* Pound boosted by UK Oxford/AstraZeneca vaccine approval

* Aussie, Kiwi gain versus dollar

* Graphic: World FX rates in 2020 https://tmsnrt.rs/2RBWI5E

LONDON, Dec 30 (Reuters) - The dollar sunk to its lowest in
more than two years in Asian trading on Wednesday and riskier
currencies surged, as investors looked past the latest delay in
U.S. fiscal stimulus and bet that global market risk appetite
would increase in 2021.

U.S. Senate Majority Leader Mitch McConnell on Tuesday
blocked a vote on increasing COVID-19 relief payments to $2,000,
adding another delay to fractious negotiations over fiscal
stimulus.

But market sentiment was upbeat as investors remained
optimistic that a fiscal stimulus deal will be eventually
reached, lessening demand for the safe-haven dollar.

The latest setback "doesn’t really matter too much for
investors as they have been over the moon on the back of news
that there is still plenty of fiscal support for the U.S.
economy," Naeem Aslam, chief market analyst at Avatrade, said in
a note.

Analysts expect the dollar to weaken further in 2021 as U.S.
President-elect Joe Biden is expected to push for even more
measures to support the U.S. economy.

The "risk-on" moves in currency markets peaked in the Asian
session on Wednesday, then eased off as European markets opened.

At 0816 GMT, the dollar was down around 0.1% versus a basket
of currencies, at 89.895, having dropped as low as 89.711
overnight. The euro was up at $1.226.

The Australian dollar - seen as a liquid proxy for global
risk appetite - was up 0.6% on the day at 0.76475 at 0825 GMT
. The New Zealand dollar also hit two-year highs
.

The dollar lost out to the Japanese yen, with dollar-yen
down 0.2% at 103.34 at 0834 GMT.

In Europe, sentiment was buoyed by Britain becoming the
first country in the world to approve the COVID-19 vaccine
developed by AstraZeneca and Oxford University.

The British pound was up against the dollar, at $1.3538, but
little changed against the euro, as traders returning from the
Christmas break digested the Brexit deal struck on Dec. 24.

Although the agreement avoids a chaotic no-deal exit, it
does not cover services, which make up 80% of the British
economy.

Commonwealth Bank of Australia senior currency strategist
Elias Haddad wrote in a note to clients that the fact that the
deal does not provide an equivalence framework for financial
service and growing support for Scottish independence are new
headwinds for the pound.

Euro zone government bond yields edged up by around one
basis point, with Germany's benchmark 10-year yield at -0.56% at
0827 GMT.

Elsewhere, Bitcoin reached a record high of $28,599.99,
taking its yearly gain for the world's most popular
cryptocurrency past 295%.

(Reporting by Elizabeth Howcroft, editing by Larry King)

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.